Published in Endocrinology on June 25, 2012
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev (2015) 2.51
Designing Endocrine Disruption Out of the Next Generation of Chemicals. Green Chem (2013) 2.47
Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union. J Clin Endocrinol Metab (2015) 1.64
Bisphenol S and F: A Systematic Review and Comparison of the Hormonal Activity of Bisphenol A Substitutes. Environ Health Perspect (2015) 1.61
Project TENDR: Targeting Environmental Neuro-Developmental Risks The TENDR Consensus Statement. Environ Health Perspect (2016) 1.50
Developmental origins of health and disease: a paradigm for understanding disease cause and prevention. Curr Opin Pediatr (2015) 1.50
Defining estrogenic mechanisms of bisphenol A analogs through high throughput microscopy-based contextual assays. Chem Biol (2014) 1.49
Does cancer start in the womb? altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors. J Mammary Gland Biol Neoplasia (2013) 1.20
Urinary bisphenol A, phthalates, and couple fecundity: the Longitudinal Investigation of Fertility and the Environment (LIFE) Study. Fertil Steril (2014) 1.14
Developmental Origins of Health and Disease: Integrating Environmental Influences. Endocrinology (2015) 1.10
Environmental public health dimensions of shale and tight gas development. Environ Health Perspect (2014) 1.09
Endocrine disruptors and obesity. Nat Rev Endocrinol (2015) 1.09
Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Endocrinology (2013) 1.08
A path forward in the debate over health impacts of endocrine disrupting chemicals. Environ Health (2014) 1.08
Regulatory decisions on endocrine disrupting chemicals should be based on the principles of endocrinology. Reprod Toxicol (2013) 1.07
Evidence that bisphenol A (BPA) can be accurately measured without contamination in human serum and urine, and that BPA causes numerous hazards from multiple routes of exposure. Mol Cell Endocrinol (2014) 1.05
Non-monotonic dose effects of in utero exposure to di(2-ethylhexyl) phthalate (DEHP) on testicular and serum testosterone and anogenital distance in male mouse fetuses. Reprod Toxicol (2012) 1.02
Metabolic disruption in male mice due to fetal exposure to low but not high doses of bisphenol A (BPA): evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation. Reprod Toxicol (2013) 1.01
Evaluation of a screening system for obesogenic compounds: screening of endocrine disrupting compounds and evaluation of the PPAR dependency of the effect. PLoS One (2013) 1.01
Bisphenol A and phthalates and endometriosis: the Endometriosis: Natural History, Diagnosis and Outcomes Study. Fertil Steril (2013) 1.01
An evo-devo approach to thyroid hormones in cerebral and cerebellar cortical development: etiological implications for autism. Front Endocrinol (Lausanne) (2014) 0.98
Implications of prenatal steroid perturbations for neurodevelopment, behavior, and autism. Endocr Rev (2014) 0.97
Should oral gavage be abandoned in toxicity testing of endocrine disruptors? Environ Health (2014) 0.96
Concerns over use of glyphosate-based herbicides and risks associated with exposures: a consensus statement. Environ Health (2016) 0.95
miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets. Mol Cell Endocrinol (2015) 0.94
Non-monotonic dose responses in studies of endocrine disrupting chemicals: bisphenol a as a case study. Dose Response (2013) 0.93
Prenatal and peripubertal phthalates and bisphenol A in relation to sex hormones and puberty in boys. Reprod Toxicol (2014) 0.92
Estrogens in the wrong place at the wrong time: Fetal BPA exposure and mammary cancer. Reprod Toxicol (2014) 0.90
Disruption of reproductive aging in female and male rats by gestational exposure to estrogenic endocrine disruptors. Endocrinology (2013) 0.90
Human infertility: are endocrine disruptors to blame? Endocr Connect (2013) 0.89
Rapid responses and mechanism of action for low-dose bisphenol S on ex vivo rat hearts and isolated myocytes: evidence of female-specific proarrhythmic effects. Environ Health Perspect (2015) 0.88
Executive Summary to EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev (2015) 0.88
Molecular mechanisms underlying the rapid arrhythmogenic action of bisphenol A in female rat hearts. Endocrinology (2013) 0.88
Non-monotonic dose-response relationships and endocrine disruptors: a qualitative method of assessment. Environ Health (2015) 0.88
Persistent organochlorine pollutants with endocrine activity and blood steroid hormone levels in middle-aged men. PLoS One (2013) 0.85
Test driving ToxCast: endocrine profiling for 1858 chemicals included in phase II. Curr Opin Pharmacol (2014) 0.85
Dynamic postnatal developmental and sex-specific neuroendocrine effects of prenatal polychlorinated biphenyls in rats. Mol Endocrinol (2013) 0.85
Homology modeling, molecular docking, and molecular dynamics simulations elucidated α-fetoprotein binding modes. BMC Bioinformatics (2013) 0.85
Early-life Exposure to Endocrine Disrupting Chemicals and Later-life Health Outcomes: An Epigenetic Bridge? Aging Dis (2014) 0.85
Impact of bisphenol a on the cardiovascular system - epidemiological and experimental evidence and molecular mechanisms. Int J Environ Res Public Health (2014) 0.85
Expressomal approach for comprehensive analysis and visualization of ligand sensitivities of xenoestrogen responsive genes. Proc Natl Acad Sci U S A (2013) 0.84
Xenoestrogens alter estrogen receptor (ER) α intracellular levels. PLoS One (2014) 0.84
On the Utility of ToxCast™ and ToxPi as Methods for Identifying New Obesogens. Environ Health Perspect (2016) 0.84
Persistent organic pollutants and early menopause in U.S. women. PLoS One (2015) 0.83
Environmental endocrine disruptors: Effects on the human male reproductive system. Rev Endocr Metab Disord (2015) 0.83
Obesogens: an emerging threat to public health. Am J Obstet Gynecol (2016) 0.83
Endocrine-Disrupting Chemicals and Oil and Natural Gas Operations: Potential Environmental Contamination and Recommendations to Assess Complex Environmental Mixtures. Environ Health Perspect (2015) 0.83
Clarity in the face of confusion: new studies tip the scales on bisphenol A (BPA). Andrology (2016) 0.83
Transgenerational effects of obesogens and the obesity epidemic. Curr Opin Pharmacol (2014) 0.82
Similar causes of various reproductive disorders in early life. Asian J Androl (2013) 0.82
Molecular Mechanisms of Action of BPA. Dose Response (2015) 0.82
Prenatal Exposure to BPA and Offspring Outcomes: The Diabesogenic Behavior of BPA. Dose Response (2015) 0.82
Assessing dose-response relationships for endocrine disrupting chemicals (EDCs): a focus on non-monotonicity. Environ Health (2015) 0.81
Early-life exposure to EDCs: role in childhood obesity and neurodevelopment. Nat Rev Endocrinol (2016) 0.81
Perinatal exposure to endocrine disruptors: sex, timing and behavioral endpoints. Curr Opin Behav Sci (2015) 0.81
Endocrine-disrupting actions of PCBs on brain development and social and reproductive behaviors. Curr Opin Pharmacol (2014) 0.80
In ovo inhibition of steroid metabolism by bisphenol-A as a potential mechanism of endocrine disruption. Proc Biol Sci (2013) 0.80
Biomarkers linking PCB exposure and obesity. Curr Pharm Biotechnol (2014) 0.80
Historical review of the causes of cancer. World J Clin Oncol (2016) 0.79
A Rat α-Fetoprotein Binding Activity Prediction Model to Facilitate Assessment of the Endocrine Disruption Potential of Environmental Chemicals. Int J Environ Res Public Health (2016) 0.79
Influence of Low-Level Prenatal Exposure to PCDD/Fs and PCBs on Empathizing, Systemizing and Autistic Traits: Results from the Duisburg Birth Cohort Study. PLoS One (2015) 0.79
Adverse Reproductive and Developmental Health Outcomes Following Prenatal Exposure to a Hydraulic Fracturing Chemical Mixture in Female C57Bl/6 Mice. Endocrinology (2016) 0.79
Ethinyl estradiol and other human pharmaceutical estrogens in the aquatic environment: a review of recent risk assessment data. AAPS J (2014) 0.79
Male reproductive cancers and infertility: a mutual relationship. Int J Mol Sci (2015) 0.79
Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol (2016) 0.78
Endocrine disruption in human placenta: expression of the dioxin-inducible enzyme, CYP1A1, is correlated with that of thyroid hormone-regulated genes. J Clin Endocrinol Metab (2014) 0.78
Epigenetic synthesis: a need for a new paradigm for evolution in a contaminated world. F1000 Biol Rep (2012) 0.78
Using systematic reviews for hazard and risk assessment of endocrine disrupting chemicals. Rev Endocr Metab Disord (2015) 0.78
To Cull or Not To Cull? Considerations for Studies of Endocrine-Disrupting Chemicals. Endocrinology (2016) 0.77
Associations of Peripubertal Serum Dioxin and Polychlorinated Biphenyl Concentrations with Pubertal Timing among Russian Boys. Environ Health Perspect (2016) 0.77
Risk Evaluation of Endocrine-Disrupting Chemicals: Effects of Developmental Exposure to Low Doses of Bisphenol A on Behavior and Physiology in Mice (Mus musculus). Dose Response (2015) 0.77
Serum Bisphenol A Level in Boys with Cryptorchidism: A Step to Male Infertility? Int J Endocrinol (2015) 0.76
Bisphenol a: a model endocrine disrupting chemical with a new potential mechanism of action. Endocrinology (2013) 0.76
Dialkyl phosphate urinary metabolites and chromosomal abnormalities in human sperm. Environ Res (2015) 0.76
A novel pathogenic classification of cancers. Cancer Cell Int (2014) 0.76
Peer-reviewed and unbiased research, rather than 'sound science', should be used to evaluate endocrine-disrupting chemicals. J Epidemiol Community Health (2016) 0.76
Prenatal Exposure to Perfluoroalkyl Substances and Behavioral Development in Children. Int J Environ Res Public Health (2016) 0.76
Food components and contaminants as (anti)androgenic molecules. Genes Nutr (2017) 0.75
Health policy: endocrine disrupting chemicals-how to strengthen safety assessment. Nat Rev Endocrinol (2012) 0.75
Twenty-Five Years of Endocrine Disruption Science: Remembering Theo Colborn. Environ Health Perspect (2016) 0.75
Cosmetics use and age at menopause: is there a connection? Fertil Steril (2016) 0.75
The Endocrine Society issues statement of principles. Environ Health Perspect (2012) 0.75
Early programing of uterine tissue by bisphenol A: Critical evaluation of evidence from animal exposure studies. Reprod Toxicol (2015) 0.75
Endocrine disruptors: Chemical contaminants - a toxic mixture for neurodevelopment. Nat Rev Endocrinol (2017) 0.75
A case-control study of bisphenol A and endometrioma among subgroup of Iranian women. J Res Med Sci (2017) 0.75
Disturbance in testosterone production in leydig cells by polycyclic aromatic hydevrepocarbons. Balsaenggwa Saengsig (2014) 0.75
Parabens and Human Epidermal Growth Factor Receptor Ligand Cross-Talk in Breast Cancer Cells. Environ Health Perspect (2015) 0.75
The mouse mammary gland as a sentinel organ: distinguishing 'control' populations with diverse environmental histories. Environ Health (2017) 0.75
In Vitro Effects of the Endocrine Disruptor p,p'-DDT on Human Follitropin Receptor. Environ Health Perspect (2016) 0.75
Mammary Gland Evaluation in Juvenile Toxicity Studies: Temporal Developmental Patterns in the Male and Female Harlan Sprague-Dawley Rat. Toxicol Pathol (2016) 0.75
The Increasing Prevalence in Intersex Variation from Toxicological Dysregulation in Fetal Reproductive Tissue Differentiation and Development by Endocrine-Disrupting Chemicals. Environ Health Insights (2016) 0.75
A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals. Environ Health (2016) 0.75
Two-hit exposure to polychlorinated biphenyls at gestational and juvenile life stages: 1. Sexually dimorphic effects on social and anxiety-like behaviors. Horm Behav (2015) 0.75
Endocrine Disruptors in Domestic Animal Reproduction: A Clinical Issue? Reprod Domest Anim (2015) 0.75
Methylparaben stimulates tumor initiating cells in ER+ breast cancer models. J Appl Toxicol (2016) 0.75
Longitudinal associations of age and prenatal lead exposure on cortisol secretion of 12-24 month-old infants from Mexico City. Environ Health (2016) 0.75
Concerns about direct potable reuse. Environ Health Perspect (2015) 0.75
Low-Dose Bisphenol A Exposure: A Seemingly Instigating Carcinogenic Effect on Breast Cancer. Adv Sci (Weinh) (2016) 0.75
Hepatic effects of tartrazine (E 102) after systemic exposure are independent of oestrogen receptor interactions in the mouse. Toxicol Lett (2017) 0.75
Low-level environmental metals and metalloids and incident pregnancy loss. Reprod Toxicol (2017) 0.75
Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev (2009) 9.60
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev (2012) 6.12
Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology (2006) 4.22
Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. Environ Health Perspect (2003) 4.19
Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ Health Perspect (1996) 3.34
Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters. Int J Androl (2005) 2.48
Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environ Health Perspect (2010) 2.35
Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect (2007) 2.29
Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. Environ Health Perspect (2002) 2.26
Prenatal exposure to bisphenol a at environmentally relevant doses adversely affects the murine female reproductive tract later in life. Environ Health Perspect (2009) 2.11
Transgenerational epigenetic programming of the brain transcriptome and anxiety behavior. PLoS One (2008) 2.07
Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: considerations for a congener-specific analysis. Environ Health Perspect (1989) 2.06
Stepping backward to improve assessment of PCB congener toxicities. Environ Health Perspect (1998) 1.98
Polychlorinated biphenyls (PCBs): routes of exposure and effects on human health. Rev Environ Health (2006) 1.92
Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. Reprod Toxicol (2006) 1.92
Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A. Environ Res (2005) 1.82
Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS One (2008) 1.81
In utero exposure to bisphenol A shifts the window of susceptibility for mammary carcinogenesis in the rat. Environ Health Perspect (2010) 1.75
Disruption of thyroid hormone receptor-mediated transcription and thyroid hormone-induced Purkinje cell dendrite arborization by polybrominated diphenyl ethers. Environ Health Perspect (2010) 1.63
Investigating intergenerational differences in human PCB exposure due to variable emissions and reproductive behaviors. Environ Health Perspect (2010) 1.60
Endocrine disruptors in the etiology of type 2 diabetes mellitus. Nat Rev Endocrinol (2011) 1.60
Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation (2012) 1.48
Reproductive and developmental toxicity of phthalates. J Toxicol Environ Health B Crit Rev (2009) 1.47
Does breast cancer start in the womb? Basic Clin Pharmacol Toxicol (2008) 1.45
Oral exposure to bisphenol a increases dimethylbenzanthracene-induced mammary cancer in rats. Environ Health Perspect (2009) 1.38
Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture. Eur J Cancer Clin Oncol (1987) 1.38
Rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor β. PLoS One (2012) 1.36
Phthalate risks, phthalate regulation, and public health: a review. J Toxicol Environ Health B Crit Rev (2009) 1.22
No threshold dose for estradiol-induced sex reversal of turtle embryos: how little is too much? Environ Health Perspect (1999) 1.22
Importance of dosage standardization for interpreting transcriptomal signature profiles: evidence from studies of xenoestrogens. Proc Natl Acad Sci U S A (2006) 1.16
Exploration of dimensions of estrogen potency: parsing ligand binding and coactivator binding affinities. J Biol Chem (2011) 1.15
Low phytoestrogen levels in feed increase fetal serum estradiol resulting in the "fetal estrogenization syndrome" and obesity in CD-1 mice. Environ Health Perspect (2008) 1.15
Nongenomic signaling pathways of estrogen toxicity. Toxicol Sci (2009) 1.13
Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences. Neurotoxicology (2011) 1.10
Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy. Endocr Relat Cancer (2010) 1.10
Transgenerational neuroendocrine disruption of reproduction. Nat Rev Endocrinol (2011) 1.10
The history of DES, lessons to be learned. Pharm World Sci (2005) 1.06
Agonist efficacy and receptor desensitization: from partial truths to a fuller picture. Br J Pharmacol (2009) 1.06
Individual polychlorinated biphenyl (PCB) congeners produce tissue- and gene-specific effects on thyroid hormone signaling during development. Endocrinology (2011) 1.05
Transgenerational effects of Di (2-ethylhexyl) phthalate in the male CRL:CD(SD) rat: added value of assessing multiple offspring per litter. Toxicol Sci (2009) 1.04
Licorice inhibits 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action. Endocrinology (1993) 1.02
The critical time window for androgen-dependent development of the Wolffian duct in the rat. Endocrinology (2007) 1.01
Chronic oral exposure to bisphenol A results in a nonmonotonic dose response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice. Environ Health Perspect (2011) 0.98
No-threshold dose-response curves for nongenotoxic chemicals: findings and applications for risk assessment. Environ Res (2005) 0.97
Effects of microsomal enzyme inducers on thyroid-follicular cell proliferation, hyperplasia, and hypertrophy. Toxicol Appl Pharmacol (1999) 0.95
Toxicology: The big test for bisphenol A. Nature (2010) 0.95
Multiple adverse thyroid and metabolic health signs in the population from the area heavily polluted by organochlorine cocktail (PCB, DDE, HCB, dioxin). Thyroid Res (2009) 0.94
PCBs exert an estrogenic effect through repression of the Wnt7a signaling pathway in the female reproductive tract. Environ Health Perspect (2006) 0.94
Endocrine disrupter bisphenol A increases in situ estrogen production in the mouse urogenital sinus. Biol Reprod (2010) 0.92
Identification of the functional domain of thyroid hormone receptor responsible for polychlorinated biphenyl-mediated suppression of its action in vitro. Environ Health Perspect (2008) 0.92
Effects of microsomal enzyme inducers on thyroid follicular cell proliferation and thyroid hormone metabolism. Toxicol Pathol (2001) 0.92
Evaluation of EPA's Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening results. Regul Toxicol Pharmacol (2011) 0.92
Essential roles of androgen signaling in Wolffian duct stabilization and epididymal cell differentiation. Endocrinology (2011) 0.92
Developmental toxicity testing for safety assessment: new approaches and technologies. Birth Defects Res B Dev Reprod Toxicol (2011) 0.90
4-Hydroxy-PCB106 acts as a direct thyroid hormone receptor agonist in rat GH3 cells. Mol Cell Endocrinol (2006) 0.90
Pubertal administration of DEHP delays puberty, suppresses testosterone production, and inhibits reproductive tract development in male Sprague-Dawley and Long-Evans rats. Toxicol Sci (2009) 0.89
Molecular determinants of hormone mimicry: halogenated aromatic hydrocarbon environmental agents. J Toxicol Environ Health B Crit Rev (1998) 0.88
Neuroendocrine disruption: historical roots, current progress, questions for the future. Front Neuroendocrinol (2010) 0.85
Kinetic and thermodynamic characterization of dihydrotestosterone-induced conformational perturbations in androgen receptor ligand-binding domain. Mol Endocrinol (2009) 0.85
The effect of hydroxylated polychlorinated biphenyl (OH-PCB) on thyroid hormone receptor (TR)-mediated transcription through native-thyroid hormone response element (TRE). Ind Health (2010) 0.84
Current and potential rodent screens and tests for thyroid toxicants. Crit Rev Toxicol (2007) 0.84
Metabolism of di (2-ethylhexyl) phthalate (DEHP): comparative study in juvenile and fetal marmosets and rats. J Toxicol Sci (2012) 0.84
Fundamentals of health risk assessment. Use, derivation, validity and limitations of safety indices. Risk Anal (1999) 0.83
Wolffian duct differentiation by physiological concentrations of androgen delivered systemically. Dev Biol (2009) 0.82
Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation. Toxicol In Vitro (2012) 0.82
Evidence for decreasing quality of semen during past 50 years. BMJ (1992) 17.44
Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet (1993) 12.83
Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect (1993) 10.04
NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci U S A (1982) 4.95
Estrogenicity of resin-based composites and sealants used in dentistry. Environ Health Perspect (1996) 4.93
Male reproductive health and environmental xenoestrogens. Environ Health Perspect (1996) 4.11
Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners. Lancet (1998) 3.34
Regional differences in semen quality in Europe. Hum Reprod (2001) 3.19
Cellular applications of 31P and 13C nuclear magnetic resonance. Science (1979) 3.14
Pesticides and inner-city children: exposures, risks, and prevention. Environ Health Perspect (1999) 3.04
Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect (2001) 3.00
In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod (2001) 2.96
Application of health information to hazardous air pollutants modeled in EPA's Cumulative Exposure Project. Toxicol Ind Health (1998) 2.73
The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A. Environ Health Perspect (2001) 2.71
Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet (2004) 2.69
Possible carcinoma-in-situ of the testis. Lancet (1972) 2.68
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
The role of estrogens on the proliferation of human breast tumor cells (MCF-7). J Steroid Biochem (1985) 2.63
Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl (1987) 2.61
Designing Endocrine Disruption Out of the Next Generation of Chemicals. Green Chem (2013) 2.47
Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci U S A (1989) 2.28
Semen quality of fertile US males in relation to their mothers' beef consumption during pregnancy. Hum Reprod (2007) 2.26
National estimates of outdoor air toxics concentrations. J Air Waste Manag Assoc (1999) 2.26
Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab (1994) 2.21
Phosphorus nuclear magnetic resonance of fast- and slow-twitch muscle. Am J Physiol (1985) 2.21
Phosphorus-31 nuclear magnetic resonance studies of the effect of oxygen upon glycolysis in yeast. Biochemistry (1981) 2.17
An updated review of environmental estrogen and androgen mimics and antagonists. J Steroid Biochem Mol Biol (1998) 2.13
Evidence for increasing incidence of abnormalities of the human testis: a review. Environ Health Perspect (1993) 2.09
Carcinoma in situ of the testis: frequency and relationship to invasive germ cell tumours in infertile men. Histopathology (1978) 2.07
Dose comparison trial of sustained-release fampridine in multiple sclerosis. Neurology (2008) 2.04
Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Environ Health Perspect (1999) 2.03
Impaired Leydig cell function in infertile men: a study of 357 idiopathic infertile men and 318 proven fertile controls. J Clin Endocrinol Metab (2004) 2.02
Air toxics and health risks in California: the public health implications of outdoor concentrations. Risk Anal (2000) 2.01
Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab (1997) 1.99
Recent adverse trends in semen quality and testis cancer incidence among Finnish men. Int J Androl (2011) 1.96
A study of finger lengths, semen quality and sex hormones in 360 young men from the general Danish population. Hum Reprod (2005) 1.94
31P nuclear magnetic resonance measurements of ATPase kinetics in aerobic Escherichia coli cells. Proc Natl Acad Sci U S A (1977) 1.86
Regulation of oxygen consumption in fast- and slow-twitch muscle. Am J Physiol (1992) 1.81
Spatio-temporal analysis of molecular delivery through the blood-brain barrier using focused ultrasound. Phys Med Biol (2007) 1.81
Inhibin A, inhibin B, follicle-stimulating hormone, luteinizing hormone, estradiol, and sex hormone-binding globulin levels in 473 healthy infant girls. J Clin Endocrinol Metab (2003) 1.81
Evaluating the health significance of hazardous air pollutants using monitoring data. Public Health Rep (2001) 1.80
High-resolution 13C nuclear magnetic resonance studies of glucose metabolism in Escherichia coli. Proc Natl Acad Sci U S A (1978) 1.79
Low-dose bioactivity of xenoestrogens in animals: fetal exposure to low doses of methoxychlor and other xenoestrogens increases adult prostate size in mice. Toxicol Ind Health (1999) 1.78
Risk of testicular cancer in subfertile men: case-control study. BMJ (1999) 1.77
Risk of testicular cancer in men with abnormal semen characteristics: cohort study. BMJ (2000) 1.73
High frequency of sub-optimal semen quality in an unselected population of young men. Hum Reprod (2000) 1.69
Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Arch Intern Med (1990) 1.67
Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet (1989) 1.63
Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark. Cancer Causes Control (1997) 1.62
Cryptorchidism and hypospadias in sons of gardeners and farmers. Environ Health Perspect (1998) 1.60
Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab (1998) 1.60
Does moderate alcohol consumption affect fertility? Follow up study among couples planning first pregnancy. BMJ (1998) 1.57
Translational repression of E2F1 mRNA in carcinoma in situ and normal testis correlates with expression of the miR-17-92 cluster. Cell Death Differ (2007) 1.55
13C nuclear magnetic resonance studies of anaerobic glycolysis in suspensions of yeast cells. Proc Natl Acad Sci U S A (1979) 1.55
Time to pregnancy and semen parameters: a cross-sectional study among fertile couples from four European cities. Hum Reprod (2002) 1.55
Spontaneous abortion and physical strain around implantation: a follow-up study of first-pregnancy planners. Epidemiology (2000) 1.54
The activity of creatine kinase in frog skeletal muscle studied by saturation-transfer nuclear magnetic resonance. Biochem J (1981) 1.53
Exclusion of SNRPN as a major determinant of Prader-Willi syndrome by a translocation breakpoint. Nat Genet (1996) 1.53
Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab (1995) 1.51
Quantitative comparisons of in vitro assays for estrogenic activities. Environ Health Perspect (2000) 1.49
Studies of the locus for androgen receptor: localization on the human X chromosome and evidence for homology with the Tfm locus in the mouse. Proc Natl Acad Sci U S A (1981) 1.48
A follow-up study of environmental and biologic determinants of fertility among 430 Danish first-pregnancy planners: design and methods. Reprod Toxicol (1998) 1.46
Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours. Histopathology (2005) 1.45
Complete androgen insensitivity syndrome: long-term medical, surgical, and psychosexual outcome. J Clin Endocrinol Metab (2000) 1.44
Histological evaluation of the human testis--approaches to optimizing the clinical value of the assessment: mini review. Hum Reprod (2006) 1.44
[Decline in semen quality from 1930 to 1991]. Ugeskr Laeger (1993) 1.43
High frequency of DAZ1/DAZ2 gene deletions in patients with severe oligozoospermia. Mol Hum Reprod (2002) 1.43
31P NMR spectroscopy, chemical analysis, and free Mg2+ of rabbit bladder and uterine smooth muscle. J Biol Chem (1986) 1.43
Negative controls of cell proliferation: human prostate cancer cells and androgens. Cancer Res (1989) 1.41
Use of time clocks for employees in health-care institutions. Am J Hosp Pharm (1990) 1.41
DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours. Oncogene (2007) 1.40
Carcinoma in situ of the testis: review of biological and clinical features. Int J Cancer (1999) 1.40
Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: case-control studies in Denmark. Cancer Causes Control (1996) 1.39
A controlled study on serum insulin-like growth factor-I and urinary excretion of growth hormone in fibromyalgia. J Rheumatol (1995) 1.39
[Hormonal treatment of testicular retention]. Ugeskr Laeger (1991) 1.39
Insulin-like growth factor-I in celiac disease. J Pediatr Gastroenterol Nutr (1994) 1.38
Mechanism of estrogen action on cellular proliferation: evidence for indirect and negative control on cloned breast tumor cells. Biochem Biophys Res Commun (1984) 1.37
[Deep-freezing of semen from cancer patients--a public task?]. Ugeskr Laeger (1995) 1.37
The two faces of janus: sex steroids as mediators of both cell proliferation and cell death. J Natl Cancer Inst (2001) 1.37
Risk factors for cryptorchidism and hypospadias. J Urol (1999) 1.36
Exposure to exogenous estrogens in food: possible impact on human development and health. Eur J Endocrinol (1999) 1.35
Retinoblastoma protein disrupts interactions required for RNA polymerase III transcription. Mol Cell Biol (2000) 1.34
P nuclear magnetic resonance studies of isolated rat liver cells. Nature (1978) 1.34
Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab (1997) 1.33
A fast, reliable, automatic shimming procedure using 1H chemical-shift-imaging spectroscopy. J Magn Reson B (1995) 1.33
A new method for spectral decomposition using a bilinear Bayesian approach. J Magn Reson (1999) 1.32
Quantification of germ cells and seminiferous tubules by stereological examination of testicles from 50 boys who suffered from sudden death. Int J Androl (1983) 1.32
Adverse trends in male reproductive health: we may have reached a crucial 'tipping point'. Int J Androl (2008) 1.31
Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. J Clin Endocrinol Metab (1997) 1.30
Familial gynecomastia with increased extraglandular aromatization of plasma carbon19-steroids. J Clin Invest (1985) 1.29
Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab (1999) 1.29
Intrauterine position effects on steroid metabolism and steroid receptors of reproductive organs in male mice. Biol Reprod (1992) 1.29
Testicular development in the complete androgen insensitivity syndrome. J Pathol (2006) 1.29
Subclinical cerebrovascular disease in mild cognitive impairment. Neurology (2009) 1.28
Androgen receptor gene mutations in human prostate cancer. Proc Natl Acad Sci U S A (1992) 1.28
Hypospadias in a cohort of 1072 Danish newborn boys: prevalence and relationship to placental weight, anthropometrical measurements at birth, and reproductive hormone levels at three months of age. J Clin Endocrinol Metab (2005) 1.28
Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, and follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels. J Clin Endocrinol Metab (1997) 1.27
Application of 31P-NMR spectroscopy to the study of striated muscle metabolism. Am J Physiol (1982) 1.26
Development of a marker of estrogenic exposure in human serum. Clin Chem (1995) 1.26
Carcinoma-in-situ of the undescended testis. Urol Clin North Am (1982) 1.26